1. National Cancer Institute Cancer Therapy Evaluation Program Common Toxicity Criteria for Adverse Events v3.0 [homepage on the Internet]. Bethesda (MD). Available at: http://ctep.cancer.gov/reporting/ctc_v30.html. Accessed October 24, 2006.
2. Amgen [homepage on the Internet]. Thousand Oaks (Calif); c.2000-5. Available at: http://wwwext.amgen.com/pdfs/products/vectibix_pi.pdf. Accessed October 24, 2006.
3. Consensus report of the international society of gastrointestinal oncology on therapeutic progress in advanced pancreatic cancer;Hochster;Cancer,2006
4. Targeting epidermal growth factor receptor signaling in the treatment of head and neck cancer;Astsaturov;Expert Rev Anticancer Ther,2006
5. Epidermal growth factor receptor pathway inhibitors;Baselga;Cancer Chemother Biol Response Modif,2005